Hip implant maker Zimmer Biomet lowered its annual profit forecast on Wednesday following last month's disruptions to a software platform that was managing some of the company's operations.
Zimmer Biomet Holdings, Inc (NYSE:ZBH) announced plans to phase out its CPT Hip System by December. The decision comes on the ...
Zimmer Biomet has hired The Terminator to tell the world that “if you rest, you rust.” The manufacturer of orthopedic medtech ...
Also Read: Zimmer Biomet To Stop Selling CPT Hip Implant System By End Of 2024 Due To High Fracture Risks Sports Medicine products generated sales of $454.2 million, up 7.3%. “We are pleased ...
Shares of Zimmer Biomet Holdings Inc. ZBH rose 3.39% to $112.54 Friday, on what proved to be an all-around grim trading ...
Zimmer Biomet Holdings ... office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and ...
President and Chief Executive Officer of Zimmer Biomet. "Through a series of strategic acquisitions and in-house innovations, we've curated a diversified portfolio of hip implant solutions and ...
In a report released yesterday, Richard Newitter from Truist Financial maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research ...